Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Fecal microbiota transplantation as a salvage therapy for concomitant resistant digestive graft versus host disease and cryptosporidiosis in a patient post hematopoietic stem cell transplant : about a case

    Thomas Finotto, Carole Chevenet, Amandine Fayard
    e2025035
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.035
    1042
    PDF: 818
    HTML: 89
  • Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Myelodysplastic Neoplasm with Complex Karyotype and ETV6 Variant: Challenges in Treatment

    Elaiza Almeida Antônio de Kós , Viviane Lamim Lovatel , Rita de Cássia Barbosa Tavares , Gerson Moura Ferreira , Bernadete Evangelho Gomes, Ana Paula Silva Bueno, Elaine Sobral da Costa , Teresa de Souza Fernandez
    e2024040
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.040
    807
    PDF: 974
    HTML: 96
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    7657
    PDF: 2442
    HTML: 1740
    Table 1.: 214
    Table 2.: 224
    Table 3.: 208
    Table 4.: 209
  • Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples

    Antonio Amato, Piero C Giordano
    e2009007
    2009-08-07
    1200
    PDF: 486
    HTML: 1168
    Amato1: 171
    Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 244
    jdoe, : 252
    Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 162
  • THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

    Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir
    e2021013
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.013
    1577
    PDF: 552
    HTML: 288
  • Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy

    Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca
    e2018069
    2018-10-29
    https://doi.org/10.4084/mjhid.2018.069
    1610
    PDF: 990
    HTML: 201
  • Lung Clear “Sugar” Cell Tumor and Jak V617f Positive Essential Thrombocythemia: A simple Co?nc?dence?

    Volkan Yazak, Gokhan Sargin, Irfan Yavasoglu, Gurhan Kadikoylu, Canten Tataroglu, Gokay Bozkurt, Zahit Bolaman
    e2013021
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.021
    1287
    PDF: 718
    HTML: 2631
  • LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA

    Alberto Piperno
    e2026051
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.051
    134
    PDF: 69
    Suppl. Files: 12
    HTML: 1
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1245
    PDF: 1082
    HTML: 206
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    1150
    PDF: 938
    HTML: 419
  • ACQUIRED REFRACTORY IRON DEFICIENCY

    Margherita Migone De Amicis, Alessandro Rimondi, Luca Elli, Irene Motta
    e2021028
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.028
    3406
    PDF: 1148
    HTML: 1089
  • Response to Interferon-Free Direct Antivirals (DAAS) Treatment in HCV-Related Subcutaneous Lipoma-Like Marginal Zone B-Cell Lymphoma

    Maria Lucia De Luca, Laura Lombardi, Germana Tartaglia, Francesca Fazio, Alessio Di Prima, Laura Cesini, Alessandra Serrao, Martina Canichella, Alessandro Pulsoni
    e2019053
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.053
    1180
    PDF: 852
    HTML: 198
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN

    Ramzi Jeddi, Hèla Ghédira, Ramzi Ben Amor, Yosr Ben Abdennebi, Kacem Karima, Zarrouk Mohamed, Hend Ben Neji, Lamia Aissaoui, Raihane Ben Lakhal, Naouel Ben Salah, Samia Menif, Zaher Belhadjali, Hela Ben Abid, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb
    e2011033
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.033
    3969
    PDF: 762
    HTML: 1852
  • VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES

    Sanaa M. Kamal, Sara Mahmoud, Tamer Hafez, Runia EL Fouly
    e2010001
    2010-02-09
    https://doi.org/10.4084/mjhid.2010.001
    1261
    PDF: 650
    HTML: 7734
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2621
    PDF: 944
    HTML: 551
  • DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.

    Federica Sorà, patrizia chiusolo, luca laurenti, idanna innocenti, francesco autore, sabrina giammarco, elisabetta metafuni, eleonora alma, alessia di giovanni, simona sica, andrea bacigalupo
    e2020055
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.055
    1222
    PDF: 687
    HTML: 311
451 - 466 of 466 items << < 5 6 7 8 9 10 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.